GIM
RDY icon

Glenmede Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Glenmede Investment Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$181K Sell
12,937
-91
-0.7% -$1.31K ﹤0.01% 1278
2025
Q2 		$196K Buy
+13,028
New +$186K ﹤0.01% 1234

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Glenmede Investment Management's RDY Position: Q3 2025 in Review

Glenmede Investment Management reduced its Dr. Reddy's Laboratories (RDY) stake by 0.7% in Q3 2025, selling an estimated $1.31K and leaving 12,937 shares worth $181K. The position accounts for ﹤0.01% of the portfolio, ranked #1278.

Glenmede Investment Management first reported a position in RDY in Q2 2025 and has held it in 2 quarters since. The position peaked at $196K in Q2 2025. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2025.

  • Glenmede Investment Management held 12,937 shares of Dr. Reddy's Laboratories worth $181K as of Q3 2025.
  • Glenmede Investment Management sold 91 Dr. Reddy's Laboratories shares in Q3 2025, an estimated $1.31K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #1278 holding.
  • Glenmede Investment Management first reported a position in Dr. Reddy's Laboratories in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Dr. Reddy's Laboratories position peaked at $196K in Q2 2025.
  • 228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.